Value-Based Oncology Conference
The daylong meeting focused on the delivery of care across various types of cancer in the community and academic setting. The primary areas of change identified during the meeting included site of service variation, reducing healthcare waste, and the need to assess the total cost of care when determining value.
Andrew L. Pecora, MD, from the Hackensack University Medical Center and John Theurer Cancer Center, let the workshop. Pecora is the founder of COTA, an innovative company focused on transitioning from fee-for-service to value-based reimbursement models through the utilization of real-world data.
"The meeting was fundamentally important, because you have a broad constituency addressing this issue of value,"" said Pecora. "This meeting allowed us to dissect the issues, and we've come away with a call to action that physicians, nurses, and pharmacists are going to pay serious attention to and start thinking about ways to help, to find solutions to this value and expenditure problem so that patients can get the drugs they need.""
IVBM's VBOnc Conference Workshop took a unique look at the delivery of value-based care by focusing on individual types of cancer, unlike other frameworks that focus on cancer as a whole. The workshop pulled together disease-specific experts, practice managers, and community oncologists to discuss the delivery of value-based care.
"An institute, fundamentally, allows for a group of people who are experts in disperse topics to come together to bring all of the facets together that you need to solve a complex problem?and clearly healthcare and healthcare expenditures is a complex problem,"" said Pecora. "I think this value-based institute is fundamentally important."
A growing burden has been placed on the healthcare system by the rising costs associated with cancer, which have substantially outpaced other healthcare expenditures. The panelists at the VBOnc Conference Workshop suggested that cutting waste, streamlining care, and cutting burdensome and costly programs could reverse this trend.
"One of the most rewarding and exciting parts of this meeting is that people came together to develop an idea/concept sheet that will address the issue of costs and the idea that this is a zero-sum game,"" said Pecora. "We can't increase total expenditures, we have to stop the increase and reduce while maintaining the outcomes.""
The panel of expert proposed five sweeping changes that were required in order to bring about change and lower costs:
- Cutting administrative waste that doesn't improve patient care
- Value-based insurance reform, with a focus on site of service differences
- Biopharmaceutical reforms to bring about faster approvals and label updates
- Provider reform to provide the best care while cutting waste
- The need to base decisions on real world versus academic data
Regarding the plan, Pecora noted, "this plan had to be actionable. It can't just be complaining or window-dressing the problem any further, it has to be this, then that, then that.""
In addition to an overarching plan for reducing costs, the workshop revealed tumor-type specific areas of change and areas for improvement. The findings focused on breast cancer, lung cancer, gastrointestinal cancers, and other types of malignancies. Findings from the VBOnc Conference Workshop will be published in a White Paper on the IVBM website in April 2016.